Statistics on Biotechnology Use Results by fields of operation Company sector. Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production Unidades: specified in variables Total Main Secondary dwellings Tool Companies that carry out R&D in Biotechnology 1.233 615 178 440 %Companies according to biotechnology used: Genetic code 31,7 40,8 21,9 22,8 %Companies according to biotechnology used: Functional units 38,5 45,5 38,3 28,8 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 22,8 28,2 21,2 15,7 %Companies according to biotechnology used: Bioprocesses 53,4 46,9 57,3 60,8 %Companies according to biotechnology used: Sub-cellular organisms 8,6 12,5 5,2 4,6 %Companies according to biotechnology used: Bio-computing 22,3 31,7 15,1 12 %Companies according to biotechnology used: Nanobiotechnology 10,6 13,9 15,2 4,3 %Companies according to biotechnology used: Other 14,2 14,8 17,1 12,2 %Company by field(s) of ultimate application of biotechnology use: Human Health 46,3 63 37,1 26,6 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 16,2 19,7 16,9 11,2 %Company by field(s) of ultimate application of biotechnology use: Food products 32 24,2 29,9 43,9 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 24,6 22,5 30,1 25,3 %Company by field(s) of ultimate application of biotechnology use: Environment 15,5 13,7 26,8 13,4 %Company by field(s) of ultimate application of biotechnology use: Industry 12,9 14,3 22,6 6,9 Personnel in R&D in biotechnology (no. of persons) 13.444 7.243 1.822 4.379 Personnel in R&D in biotechnology (no. of persons): Researchers 7.378 4.139 1.032 2.207 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 6.066 3.105 790 2.171 Personnel in R&D in biotechnology (no. of persons): women 7.501 4.255 917 2.329 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 4.052 2.352 542 1.158 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 3.450 1.903 376 1.171 Personnel in R&D in biotechnology (FTE) 9.401,9 5.696,8 1.025,3 2.679,9 Personnel in R&D in biotechnology (FTE): Researchers 5.398,3 3.332,7 675,7 1.389,9 Personnel in R&D in biotechnology (FTE): Technicians and assistants 4.003,6 2.364,1 349,5 1.290 Personnel in R&D in biotechnology (FTE): women 5.426,2 3.428,5 556,8 1.440,9 Personnel in R&D in biotechnology (FTE): (women) Researchers 3.016,4 1.924,6 360,1 731,7 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 2.409,8 1.503,9 196,7 709,2 Internal expenditure on R&D (thousands of euros) 897.333 602.520 77.601 217.211 1) By nature of the expense: Current expenses 817.409 541.269 71.986 204.154 1.1) Remuneration to researchers 295.705 194.401 32.922 68.382 1.2) Remuneration to technicians and assistants 156.853 98.937 11.856 46.060 1.3) Other current expenses 364.852 247.931 27.209 89.712 2) By nature of the expense: Capital expenses 79.924 61.251 5.615 13.057 2.1) Land and buildings 10.272 8.482 898 892 2.2) Equipment and instruments 56.609 41.244 4.323 11.043 2.3) Acquisition of specific R+D software 4.839 4.254 109 476 2.4) Otros productos de propiedad intelectual específicos para I+D 8.203 7.271 286 647 1.1) By origin of the funds: Own funds 613.097 418.567 47.014 147.516 1.2) By origin of the funds: From companies 86.085 44.282 10.408 31.395 1.3) By origin of the funds: Public Administration funds 92.140 56.901 11.393 23.846 1.4) By origin of the funds: From Universities 853 519 0 335 1.5) By origin of the funds: From non profit private institutions 4.682 1.965 0 2.717 1.6) By origin of the funds: Foreign funds 100.476 80.287 8.786 11.403 Purchase of R&D services in biotechnology (thousands of euros) 85.011 62.516 14.617 7.878 Purchase of R&D services in biotechnology (thousands of euros): In Spain 54.243 36.965 11.023 6.255 Purchase of R&D services in biotechnology (thousands of euros): Abroad 30.768 25.552 3.594 1.622 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 39,2 48,3 36,5 27,7 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 11,7 10,9 15,3 11,4 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 12,5 12,7 12,8 12,1 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 10,9 12 9,4 9,9 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets 14 16 14 12 %Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels 17 21 15 11 %Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception 15 16 15 14 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 36 42 35 27 %Companies that consider the following obstacles as very important considering biotechnology development : Time / cost 47 53 44 39 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 19 21,8 17,6 15,6 % Companies that have requested biotechnology patents 17 25 16 7 Number of patents requested 681 473 65 144 % Companies with income of an international origin related to biotechnological activities 23 28,9 17,9 17 % Turnover representing income of an international origin related to biotechnological activities 1,6 9,4 0,1 0,6 % Income of of an international origin related to biotechnological activities distributed in: Income received from the EU 56 56 74 49 % Income of of an international origin related to biotechnological activities distributed in: Income received from other countries 44 44 26 51 % Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services 84 82 82 96 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 14,7 17,1 2 0,4 % Income of an international origin related with activities according to the classification: Operating source abroad 0,8 0,2 15,5 1,6 % Income of an international origin related with activities according to the classification: Other 0,6 0,5 0,2 1,5 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute